Arlington Partners LLC Eli Lilly & CO Transaction History

Arlington Partners LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	SELL	$525.19 - $619.13 $51,468 - $60,674	-98 Reduced 21.44%	359 $209,000
Q3 2023 Oct 24, 2023	SELL	$434.7 - $599.3 $122,585 - $169,002	-282 Reduced 38.16%	457 $245,000
Q2 2023 Jul 26, 2023	BUY	$350.74 - $468.98 $46,297 - $61,905	132 Added 21.75%	739 $346,000
Q1 2023 Apr 26, 2023	BUY	$310.63 - $364.82 $64,921 - $76,247	209 Added 52.51%	607 $208,000
Q4 2022 Jan 19, 2023	BUY	$321.55 - $374.67 $31,833 - $37,092	99 Added 33.11%	398 $146,000
Q3 2022 Oct 28, 2022	SELL	$296.48 - $337.87 $57,517 - $65,546	-194 Reduced 39.35%	299 $97,000
Q2 2022 Jul 25, 2022	BUY	$278.73 - $327.27 $45,990 - $53,999	165 Added 50.3%	493 $160,000
Q1 2022 Apr 14, 2022	BUY	$234.69 - $291.66 $6,806 - $8,458	29 Added 9.7%	328 $94,000
Q4 2021 Jan 18, 2022	BUY	$224.85 - $279.04 $67,230 - $83,432	299 New	299 $83,000
Q3 2018 Oct 23, 2018	SELL	$85.86 - $107.31 $19,576 - $24,466	-228 Closed	0 $0
Q1 2018 May 07, 2018	BUY	$74.21 - $87.6 $16,919 - $19,972	228 New	228 $18,000

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Arlington Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Arlington Partners LLC with notifications on news.